Related Experiment Video
Updated: Feb 14, 2026
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Recent advances in non-pharmacological interventions for symptom burden management in breast cancer patients treated
Yuan Li1, Yunyun Chen2, Suxing Wang3
1School of Nursing, Shanghai Jiao Tong University, Shanghai, China.
Objective:
Ovarian function suppression (OFS) treatment causes a sudden drop in patients' estrogen to postmenopausal levels, accompanied by associated side effects that are often abrupt and intense. This study aimed to provide an evidence base for clinical practice by systematically searching for the best current evidence on managing symptom burden in OFS-treated breast cancer patients.
Method:
We systematically searched relevant evidence from the creation date to 21 November 2023 in computerized decision systems, guideline networks, professional society networks, and databases. The literature type included guidelines, expert consensus, systematic review, meta-analysis, recommended practice, best practice, clinical decision-making, and evidence summary. After three researchers independently screened and evaluated the literature, two researchers integrated the evidence and checked it by a third person.
Results:
A total of 15 articles were selected, including six guidelines and nine expert consensus articles, and the overall literature quality was high. Thirty-eight pieces of evidence were summarized into eight areas: supportive elements of symptom burden management, health education, regular assessment and monitoring, diet and nutrition, exercise training, lifestyle, prevention and control of comorbidities, and complementary and alternative therapies.
Conclusion:
This study summarizes the best evidence on non-pharmacological interventions for symptom burden management in OFS-treated breast cancer patients, guiding clinical practice. As non-pharmacological interventions for symptom burden management in OFS-treated breast cancer patients are still in their infancy, the best evidence for OFS-treated breast cancer patients should be selected for clinical application in the future in a site-specific and individualized manner, and the best evidence should be continuously updated.
Related Concept Videos
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
02:22Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
01:03Nursing Interventions I: Taxonomy of Nursing Interventions
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...